Dialysis centers and ketamine clinics have both met their fair share of concerns over their safety practices and high costs. But in addition to the risk of abuse, physical infrastructure and staffing require a lot of capital. Those companies developing safer, at-home psychedelic treatments could be a way to reduce costs while also reaching a larger population.>
You must log in or register to comment.